Vista Pharmaceuticals Limited (BOM:524711)
India · Delayed Price · Currency is INR 6.28
+0.04 (0.64%)
At close: Sep 4, 2026
Vista Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Vista Pharmaceuticals had annual revenue of 100.75M INR, down -2.07%.
Revenue
100.75M
Revenue Growth
-2.07%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
30
Market Cap
386.55M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 100.75M | -2.13M | -2.07% |
| Mar 31, 2024 | 102.88M | 92.84M | 924.99% |
| Mar 31, 2023 | 10.04M | 6.09M | 154.42% |
| Mar 31, 2022 | 3.95M | -8.72M | -68.85% |
| Mar 31, 2021 | 12.66M | -214.93M | -94.44% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Mangalam Drugs & Organics | 2.32B |
| Rajnish Wellness | 1.68B |
| JFL Life Sciences | 1.31B |
| ANG Lifesciences India | 862.13M |
| Sandu Pharmaceuticals | 696.24M |
| Panjon | 492.78M |
| Gujarat Terce Laboratories | 456.22M |
Vista Pharmaceuticals News
- 23 days ago - Vista Pharmaceuticals Quarterly report: Q1 2027 - Filings
- 3 months ago - Vista Pharmaceuticals Quarterly report: Q4 2026 - Filings
- 6 months ago - Vista Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 9 months ago - Vista Pharmaceuticals Quarterly report: Q2 2026 - Filings